Skip to Content

Join the 'Hemosiderosis' group to help and get support from people like you.

Hemosiderosis News

FDA Approves Ferriprox to Treat Patients with Excess Iron in the Body

Posted 14 Oct 2011 by

October 14, 2011 – The U.S. Food and Drug Administration today approved Ferriprox (deferiprone) to treat patients with iron overload due to blood transfusions in patients with thalassemia, a genetic blood disorder that causes anemia, who had an inadequate response to prior chelation therapy. Patients with thalassemia have excess iron in the body from the frequent blood transfusions ...

Ask a Question

Further Information

Related Drug Support Groups

Exjade, deferasirox, deferiprone